Diabetes Care in China

Impacts of Traditional Chinese Medicine(TCM) and Insurance on Quality and Utilization

Zhen Wang

ResearchPublished Nov 3, 2011

Today, China is facing a serious and fast growing challenge of a diabetes epidemic. With the largest diabetic population in the world, 9.7% of Chinese aged 20 and over have diabetes. However, diabetes care is far from satisfactory. The problem is further complicated by the widespread use of Traditional Chinese Medicine (TCM) and by disparities in insurance coverage. This dissertation intends to explore quality and utilization of diabetes care in China.

Topics

Document Details

Citation

Chicago Manual of Style

Wang, Zhen, Diabetes Care in China: Impacts of Traditional Chinese Medicine(TCM) and Insurance on Quality and Utilization. Santa Monica, CA: RAND Corporation, 2011. https://www.rand.org/pubs/rgs_dissertations/RGSD286.html.
BibTeX RIS

Research conducted by

This publication is part of the RAND dissertation series. Dissertations are written by Ph.D. candidates at the RAND School of Public Policy and supervised, reviewed, and approved by a RAND School faculty committee overseeing each dissertation. The RAND School is the world's leading producer of Ph.D.'s in policy analysis.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.